1. 184 Two types of anti-TIGIT antibodies with distinct binding epitope and functional activities. (9th November 2020) Authors: Zhong, Tingting; Pang, Xinghua; Huang, Zhaoliang; Chen, Na; Jin, Xiaoping; Xia, Yu; Wang, Maxwell Zhongmin; Li, Baiyong Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19. (9th November 2020) Authors: Zhong, Tingting; Huang, Zhaoliang; Pang, Xinghua; Chen, Na; Kwek, Konyew; Wynne, Chris; Konpa, Adam; Jin, Xiaoping; Xia, Yu; Wang, Maxwell Zhongmin; Li, Baiyong; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 476 AK119, a humanized anti-CD73 monoclonal antibody, as Immunotherapy for COVID-19. (9th November 2020) Authors: Zhong, Tingting; Huang, Zhaoliang; Pang, Xinghua; Chen, Na; Kwek, Konyew; Wynne, Chris; Konpa, Adam; Jin, Xiaoping; Xia, Yu; Wang, Maxwell Zhongmin; Li, Baiyong; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 702 Dual blockade of the PD-1 checkpoint pathway and the adenosinergic negative feedback signaling pathway with a PD-1/CD73 bispecific antibody for cancer immune therapy. (9th November 2020) Authors: Zhong, Tingting; Huang, Zhaoliang; Pang, Xinghua; Chen, Na; Jin, Xiaoping; Xia, Yu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity. Issue 1 (31st December 2023) Authors: Pang, Xinghua; Huang, Zhaoliang; Zhong, Tingting; Zhang, Peng; Wang, Zhongmin Maxwell; Xia, Michelle; Li, Baiyong Journal: MAbs Issue: Volume 15:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dynamics of sediment phosphorus affected by mobile aeration: Pilot-scale simulation study in a hypereutrophic pond. (1st November 2021) Authors: Chen, Chao; Wang, Yiyao; Pang, Xinghua; Long, Lulu; Xu, Min; Xiao, Yinlong; Liu, Yan; Yang, Gang; Deng, Shihuai; He, Jingsong; Tang, Hong Journal: Journal of environmental management Issue: Volume 297(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity. Issue 11 (30th November 2022) Authors: Qu, Tailong; Zhong, Tingting; Pang, Xinghua; Huang, Zhaoliang; Jin, Chunshan; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Yu Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗